281 Followers on Owler
AgomAb is a Belgium-based biotechnology company that researches and develops novel therapies and agonistic antibodies for the treatment of organ failure and fibrotic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights
AgomAb is a Belgium-based biotechnology company that researches and develops novel therapies and agonistic antibodies for the treatment of organ failure and fibrotic diseases... Read more
Agomab CEO: Tim Knotnerus

CEO

Tim Knotnerus

CEO Approval Rating

88/100

2017

Private

Pharmaceuticals & Biotechnology
Biotechnology
8731 NAICS listing

Est. Annual Revenue
$5.0-25M
Agree?
Est. Employees
25-100
Agree?
Funding
$328.5M
Acquisitions
1

News

Funding
Oct 25, 2024
FinSMEs
Agomab received $89M in Series D Funding

Agomab Competitors

1Alentis
2NorthSea Therapeutics
3Galecto
4FibroGen
5Pliant
6VBI
7Biocept
8Guardant Health
9True Health Group LLC
10Lunaphore
Unlock 25 + competitors

Trending Companies